SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB).

SuperCom (NASDAQ: SPCB) announced a new electronic monitoring service provider contract in Louisiana, marking its entry into its 16th new U.S. state and 17th new service provider partnership since mid-2024. Under the agreement, SuperCom will serve as the primary EM technology partner for a Louisiana-based provider operating statewide supervision programs, transitioning existing GPS tracking operations to its proprietary PureSecurity(TM) platform under a recurring revenue model based on daily active units. Management stated the agreement reflects continued competitive incumbent displacement and supports the company's disciplined U.S. expansion strategy focused on scalable technology deployment and long-term partnership growth.

To view the full press release, visit https://ibn.fm/YTAPq

SuperCom Ltd. (NASDAQ: SPCB) is a global provider of secure solutions spanning electronic monitoring, e-Government, and cybersecurity markets. Since 1988, the company has supported national governments and public agencies with advanced safety, identity, and tracking technologies. Its solutions enable courts, service providers, and public safety agencies to efficiently supervise high-risk populations, improve victims’ safety and manage compliance with judicial mandates across multiple jurisdictions.

SuperCom’s growth in North America has accelerated since mid-2024, with expansion into 11 new U.S. states and more than 30 contracts secured with public safety agencies and regional service providers, displacing long-standing incumbents in the process. This expansion reflects the company’s emphasis on recurring revenue, technological differentiation, and close partnership with agencies seeking innovative, mobile-first alternatives to outdated systems.

SuperCom’s vision is to revolutionize the public safety sector through proprietary electronic monitoring technology, data intelligence, and flawless execution. Its offerings include GPS and RF-based monitoring, biometric ID verification, mobile law enforcement tools, and national-level e-ID platforms.

The company is headquartered in Tel Aviv, Israel.

Products

Electronic Monitoring and Public Safety

SuperCom’s operations are anchored by its proprietary PureSecurity™ suite, a unified offender monitoring platform combining GPS tracking, biometric verification, tamper detection, and advanced data analytics. Its PureOne™ one-piece bracelet and PureTrack™ smartphone-integrated solution offer high-precision location tracking, real-time alerts, and seamless integration with PureCom™ base stations, PureBeacon™ indoor trackers, and PureProtect™, an app designed to safeguard domestic violence victims.

The company complements its hardware with PureMonitor™, a secure, cloud-based case management system that enables real-time oversight, mobile access, and data visualization for monitoring agencies. This full-stack approach allows SuperCom to support a range of court-mandated programs including GPS monitoring, house arrest, curfew enforcement, and community supervision. The company’s domestic violence monitoring solutions are now deployed in at least seven countries.

SuperCom’s U.S. subsidiary, Leaders in Community Alternatives (LCA), provides reentry and rehabilitation services that complement the company’s electronic monitoring programs. Operating primarily in California, LCA delivers community-based solutions designed to reduce recidivism and promote successful reintegration. Its programs include individualized case management, employment support, evidence-based treatment, and day reporting centers—services that support public safety while offering alternatives to incarceration. Since LCA’s acquisition in 2016, SuperCom secured over $35 million in new contract wins in Northern California.

Cybersecurity

SuperCom also offers additional capabilities through its cybersecurity and e-Government product lines. The company’s cybersecurity subsidiary, Safend Ltd., provides endpoint data protection through its Data Protection Suite. This platform includes modules for encryption (Encryptor), port/device control (Protector), data classification (Discoverer), DLP (Inspector), audit tracking (Auditor), and compliance reporting (Reporter).

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments and national agencies design and issue secured multi-identification documents and robust digital identity solutions to their citizens, visitors, and lands. The company has focused on expanding its activities, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

SuperCom operates across multiple high-growth sectors. In electronic monitoring, rising incarceration costs, overcrowded prisons, and increased judicial adoption of alternatives to detention continue to drive demand for GPS and RF-based supervision programs. The company’s rapid expansion into 11 U.S. states and multiple national-level deployments in Europe and the EMEA region reflect a robust and growing market. According to Mordor Intelligence, the electronic offender monitoring solutions market size stands at $2.18 billion in 2025 and is projected to reach $3.19 billion by 2030.

SuperCom also addresses two important supplementary markets through its cybersecurity and e-Government offerings. In cybersecurity, growing threats to sensitive government and enterprise data are fueling investments in endpoint protection, compliance, and device control, which are areas directly served by the company’s Safend platform. In the public sector identity space, secure ID, biometric verification, and e-passport programs remain foundational to digital governance. SuperCom’s track record of delivering national ID solutions across Africa, Latin America, and Eastern Europe underscores its continued relevance in these adjacent sectors.

Leadership Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

SuperCom Ltd. (NASDAQ: SPCB), closed Thursday's trading session at $8.38, up 4.75%, on 70,675 volume. The average volume for the last 3 months is 199,866 and the stock's 52-week low/high is $1.64/$10.5.

Recent News

• SuperCom Ltd. (NASDAQ: SPCB) - TechMediaBreaks - SuperCom Ltd. (NASDAQ: SPCB) Expands into Louisiana with New Electronic Monitoring Service Provider Contract
• SuperCom Ltd. (NASDAQ: SPCB) Expands Wisconsin Footprint with Third County Deployment, Highlighting Rapid EM Scaling Model
• TechMediaBreaks - SuperCom Ltd. (NASDAQ: SPCB) Expands Electronic Monitoring Operations With Third County Deployment in Wisconsin

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF)

The QualityStocks Daily Newsletter would like to spotlight SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF).

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

SPARC AI (CSE: SPAI) (OTCQB: SPAIF) , an emerging engineering and software company primarily focused on finding solutions to some of the most difficult challenges in modern sensing and autonomy, was featured in a recent article. The piece discussed the company's efforts to strategically build high-performance tools that transform everyday sensors and imaging systems into reliable spatial intelligence platforms. "The company's core innovation lies in enabling sensors, cameras, and mobile devices, whether airborne, fixed, handheld, or portable, to operate as precise target coordination systems without needing any specialized or expensive hardware," the article reads. "The company's Target Acquisition System (‘TAS') operates as a software platform created to pinpoint the geographic location of distant objects using visual data. By leveraging advanced AI and mathematically driven models, SPARC AI's technology helps extract the spatial meaning of sensor inputs and images, providing intelligence in areas where traditional hardware-heavy solutions may not be available."

To view the full article, visit https://ibn.fm/qsbZf

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) develops next-generation, GPS-free target acquisition system and autonomous navigation software for drones and edge devices. Its zero-signature technology delivers real-time detection, tracking, and behavioral insights without reliance on radar, lidar, or heavy sensors. The company’s platform transforms unmanned systems into autonomous tools capable of identifying and engaging targets in GPS-denied environments.

The company’s vision is to redefine situational awareness by merging advanced mathematics, AI modeling, and edge computing into a unified intelligence architecture. SPARC AI aims to empower defense, rescue, and commercial organizations to operate safely and effectively in signal-contested environments where traditional navigation systems fail.

Its mission is to build the world’s most trusted geolocation intelligence platform that operates without GPS, enabling seamless interoperability across air, land, and sea devices.

SPARC AI is headquartered in Toronto, Canada.

Technology

SPARC AI’s technology suite delivers precision target acquisition, navigation, and autonomous intelligence in environments where GPS and traditional sensors fail. At its core is the Target Acquisition System, a software-only solution that determines the geolocation of any visible object using camera telemetry data. By removing the need for specialized hardware like lasers, radar, or lidar, the platform reduces weight, power use, and cost. Built on advanced mathematical modeling, it constructs a 3D understanding of terrain and position, achieving GPS-level accuracy in a zero-signature configuration suited for defense, rescue, and commercial operations.

SPARC AI Mobile extends this capability to handheld and field-issued devices, allowing operators to mark and transmit target coordinates directly from smartphones or rugged tablets. Once a target is identified, the device relays the coordinates to a connected drone, which autonomously navigates to the location for reconnaissance or engagement. The mobile system maintains accuracy even in GPS-jammed or degraded environments, turning each device into a connected node within a broader distributed network.

The company’s GPS-Denied Navigation engine enables mission planning and execution without satellite signals. Operators can design flight paths, define perimeters, and simulate routes to identify optimal vantage points and minimize resource use. Counter-surveillance and threat-prediction tools model adversarial visibility, helping users avoid detection and maximize ground coverage. Together, these capabilities form the foundation of SPARC AI’s software architecture, providing the intelligence backbone for its integrated command platform.

Overwatch Target Intelligence

Overwatch unifies all SPARC AI technologies, including its Target Acquisition, Mobile, and Navigation systems, into a single mission-ready platform that fuses detection, classification, tracking, and navigation in real time. It transforms drones and robotic systems into fully autonomous intelligence assets by synchronizing data across connected devices. The platform’s zero-signature design ensures complete operational security, allowing defense and rescue teams to conduct surveillance, reconnaissance, and engagement without GPS or active sensors.

Within Overwatch, the ATLAS Visibility Intelligence Engine enhances mission planning and reconnaissance through 2D and 3D visualization. Users can simulate line-of-sight coverage from any altitude, identify unseen or occluded areas, and optimize routes for surveillance or search and rescue. Operating entirely through software, ATLAS produces high-fidelity visibility data without mapping drones or additional power consumption, providing a lightweight, silent, and sensor-free alternative to lidar-based systems.

The SPARC AI SDK and open API framework extend Overwatch’s interoperability. Developers can embed SPARC AI’s intelligence into third-party systems such as PX4- and ArduPilot-powered drones, the world’s most widely used open-source flight platforms. The SDK provides REST APIs with bindings for Python, C++, and JavaScript and supports hardware including NVIDIA Jetson, Qualcomm Robotics RB5, and Raspberry Pi. Through these integrations, Overwatch serves as the command and intelligence layer of SPARC AI’s ecosystem, linking distributed drones, sensors, and edge devices into a coordinated autonomous network that operates entirely without GPS.

Market Opportunity

SPARC AI operates within the rapidly expanding defense, security, and commercial drone markets projected to exceed $100 billion over the next decade. The company’s software-defined approach addresses the global demand for autonomous systems capable of performing in denied, degraded, intermittent, and limited (DDIL) environments, positioning SPARC AI at the forefront of next-generation geolocation and targeting solutions.

Fortune Business Insights projects the global commercial drone market will reach approximately $65.25 billion by 2032, while Grand View Research estimates the combined drone hardware and services market will grow to $163.6 billion by 2030. With its per-device subscription model and integration across drones and robotic systems, SPARC AI is structured to capture recurring revenue from this accelerating adoption of GPS-denied intelligence technologies.

Leadership Team

Anoosh Manzoori, CEO, brings extensive experience as a technology entrepreneur, investor, and director, having founded, scaled, and exited multiple high-tech companies. He has taken five companies public, served on seven public company boards, and invested in innovations spanning cloud, fintech, biotech, IoT, defense, and AI.

Justin Hanka, Director, is an investment banking professional with 25 years of experience in mergers and acquisitions and capital markets. He has held executive roles at high-growth companies including iSelect.com.au and Helpmechoose, achieving multiple successful exits.

Anthony Haberfield, Director, is an international financial services executive with 30 years of experience across the Asia Pacific region, specializing in strategy, transformation, procurement, and emerging technology.

SPARC AI Inc. (OTCQB: SPAIF), closed Thursday's trading session at $0.87245, up 16.7313%, on 310,869 volume. The average volume for the last 3 months is 34,837 and the stock's 52-week low/high is $3.53/$5.24.

Recent News

• SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) - TechMediaBreaks - SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Advancing Software-Driven Spatial Intelligence
• NetworkNewsBreaks - SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Bringing GPS-Free Spatial Intelligence to Military and Defense
• Sparc AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Advances Spatial Computing amid Evolving Drone Challenges

Fairchild Gold Corp. (TSX.V: FAIR) (OTC: FCHDF)

The QualityStocks Daily Newsletter would like to spotlight Fairchild Gold Corp. (TSX.V: FAIR) (OTC: FCHDF).

Disseminated on behalf of Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) and may include paid advertising.

Fairchild Gold (TSX.V: FAIR) (OTCQB: FCHDF) was featured in a recent article that discussed the company's exploration-driven model focused on gold and copper, two critical metals in today's global economy. "With markets confronting a structural shift in the way supply chains, energy, and infrastructure are developed, the company is strategically positioned to leverage the latest developments. The recent rise in the price of copper to over $6 per pound, exceeding its July 2025 high, underscores increased global supply pressures at a time when decarbonization and electrification are picking up steam," the publication reads. "Fairchild Gold currently operates in an increasingly tightening supply environment as a mineral exploration company with a focus on acquiring and developing copper and gold assets in North America. The company's focus on the Americas is perfectly aligned with investor and government interest in securing domestic sources of essential minerals, especially with the global reliance on a sensitive supply chain under heavier scrutiny."

To view the full article, visit https://ibn.fm/4Y5Q3

Fairchild Gold Corp. (TSX.V: FAIR) (OTC: FCHDF) is a mineral exploration company focused on acquiring, exploring, and developing high-quality mineral properties in mining-friendly jurisdictions across North America. The company targets projects with historical production, strong multi-metal potential, and clear pathways to discovery through modern geoscience, AI integration, and responsible development practices.

Fairchild’s portfolio is anchored by the Nevada Titan Project, a district-scale, copper-gold system located just outside Las Vegas in the prolific Walker Lane Belt. The company has also entered into an MOU to acquire the advanced-stage Golden Arrow Project in Nevada, subject to completion of a definitive agreement, and it holds 100% ownership of the Fairchild Lake Property in Ontario.

Fairchild’s mission is to build long-term value by identifying overlooked mineralized systems and unlocking their potential using modern exploration methods.

The company is headquartered in Vancouver, British Columbia.

Projects

Nevada Titan Project (Goodsprings District, Nevada)

Nevada Titan is Fairchild’s flagship asset and a district-scale, multi-metal opportunity located just 55 kilometers southwest of Las Vegas. Spanning over 6,150 acres (300+ claims), the project sits within the historically productive Goodsprings Mining District—part of the prolific Walker Lane Belt and Battle Mountain Trend extension. The area hosts numerous historic mines, including Copperside, Copper Chief, Azurite, and Fitzhugh Lee, yet remains largely untested by modern drilling.

Surface sampling and geological mapping have confirmed high-grade copper mineralization up to 34.0% Cu, with associated values of gold, silver, molybdenum, and platinum group elements. A 1.5-kilometer copper-gold corridor has been identified, showing pods and lenses of mineralization consistent with a porphyry-skarn-CRD system. Notably, the discovery of a hydrothermal breccia pipe with garnet-bearing skarn textures and elevated molybdenum signals a porphyry-affiliated source at depth.

Ongoing exploration includes drone magnetics, AI-integrated targeting, and induced polarization geophysics. With infrastructure already in place and proximity to Las Vegas contractors, Fairchild is preparing for a 2026 drill campaign focused on unlocking the project’s large-scale copper-gold system.

Golden Arrow Project (Walker Lane Shear Zone, Nevada)

In September 2025, Fairchild signed a Memorandum of Understanding to acquire 100% of the Golden Arrow Project, an advanced-stage gold-silver asset in Nevada’s Walker Lane Trend. The project hosts a historic mineral resource estimate of approximately 347,000 ounces of gold and 5.3 million ounces of silver, including 296,500 ounces of gold and 4.0 million ounces of silver in the measured and indicated categories. According to third-party analysis by mining analyst Ryan D. Long, the total acquisition consideration of $5.0 million equates to approximately $12 per ounce of gold in the ground.

The project’s two main deposits, Gold Coin and Hidden Hill, were historically mined at surface and remain open at depth, supported by over 61,000 meters of past drilling. Modern geophysical work has outlined 34 additional exploration targets, including six classified as high-priority. Hosted in a volcanic complex with both high-grade vein and disseminated mineralization, the system offers strong potential for expansion.

Golden Arrow is situated just 96 kilometers from Kinross’s 28-million-ounce Round Mountain Mine and expands Fairchild’s Nevada footprint by 170% when combined with the Titan Project. The project’s extensive exploration database and near-surface deposits make the acquisition a compelling strategic entry point into a proven district with significant near-term development potential.

Fairchild Lake Property (Savant Lake Greenstone Belt, Ontario)

Fairchild Gold holds 100% ownership of the Fairchild Lake Property, a 2,224-hectare claim package in Ontario’s underexplored Savant Lake greenstone belt. Historical and recent work, including airborne geophysics and soil sampling, has identified anomalous gold values near the Kashaweogama Lake Fault, a major crustal break. The company draws geological comparisons to Red Lake’s LP Fault and views the structural setting as a promising focus for future exploration.

Market Opportunity

Fairchild operates in Tier-1 mining jurisdictions where political stability, established infrastructure, and clear permitting pathways reduce development risk and enhance long-term value. Nevada, in particular, is a top-ranked global destination for mineral exploration and home to some of the world’s most productive gold and copper belts. Fairchild’s flagship project, Nevada Titan, is located in the Walker Lane Belt, a prolific trend responsible for more than 89 million ounces of gold and nearly 1 billion ounces of silver to date.

The company is strongly positioned to benefit from the ongoing historic bull market in gold. In early October 2025, Goldman Sachs raised its December 2026 gold price forecast to $4,900 per ounce, citing strong ETF inflows and sustained central bank demand. A Jefferies analyst has projected gold could reach $6,600 per ounce in the near term, while other major institutions including UBS and Bank of America have also raised their targets amid elevated geopolitical risk, structural reserve diversification, and anticipated U.S. rate cuts. With limited new supply and rising demand from both institutional and retail investors, gold remains a cornerstone of portfolio hedging and upside exposure.

Copper also remains a core strategic focus, with demand expected to double by 2035, driven by electrification, grid modernization, and clean energy buildout, according to S&P Global. The Nevada Titan Project hosts porphyry-style copper-gold mineralization, along with skarn and carbonate replacement features—deposit types that are key global sources of both industrial and precious metals.

Leadership Team

Nikolas Perrault, CFA, Executive Chairman, brings over 35 years of experience in capital markets, securities trading, and strategic advisory roles. He began his career with Canada’s top financial institutions and has since focused on guiding small to mid-cap companies through public listings, M&A, and capital raising. He holds a Chartered Financial Analyst designation and a Bachelor of Commerce.

Luís Martins, President and CEO, brings over 40 years of experience in the exploration and mining sector. He previously served as Director of the Mineral Resources Department at Portugal’s Geological Survey and as Director of Mines and Quarries at the Directorate-General of Energy and Geology. He has coordinated international working groups focused on raw materials and mineral policy and has authored more than 100 scientific publications.

Dr. Sergei Diakov, Chair of the Technical Committee and Senior Advisor, is a globally recognized geologist and former discovery lead at both BHP and AngloGold Ashanti. His track record includes major copper-gold discoveries such as Oyu Tolgoi in Mongolia and Nuevo Chaquiro in Colombia. Dr. Diakov brings decades of senior experience managing exploration teams, overseeing risk across geologic and ESG domains, and executing discovery-driven development strategies.

Adam Cavise, Independent Director, brings over 25 years of capital markets experience and has been directly involved in structuring and closing more than $100 billion in public and private equity offerings, SPACs, and recapitalization transactions. Currently a partner at Revere Securities in New York, he has held senior equity roles at Kingswood, Spartan Capital, and Macquarie, and is well regarded for his deep Wall Street network and leadership in equity capital markets.

Fairchild Gold benefits from a deeply experienced leadership and advisory team with expertise across exploration, capital markets, and corporate development. To view the full team, click here.

Fairchild Gold Corp. (OTC: FCHDF), closed Thursday's trading session at $0.06, off by 28.1093%, on 102,395 volume. The average volume for the last 3 months is 150,083 and the stock's 52-week low/high is $0.9693/$5.84.

Recent News

• Fairchild Gold Corp. (TSX.V: FAIR) (OTC: FCHDF) - InvestorNewsBreaks - Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) Advancing North American Gold and Copper Strategy
• Fairchild Gold Corp. (TSX.V: FAIR) (OTC: FCHDF) Positions for Structural Copper Strength as Global Supply Tightens
• MiningNewsBreaks - Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) Identifies Multiple Priority Targets at Nevada Titan Project

Oncotelic Therapeutics Inc. (OTCQB: OTLC)

The QualityStocks Daily Newsletter would like to spotlight Oncotelic Therapeutics Inc. (OTCQB: OTLC).

Oncotelic Therapeutics (OTCQB: OTLC) and Sapu Bioscience announced key advancements in their global intellectual property portfolio supporting OT-101, a proprietary TGF-β antisense therapeutic platform, with allowed patent claims in Australia covering OT-101 (SEQ ID NO:9) for the treatment of Parkinson's Disease, including associated sleep-related symptoms, and granted utility model patents in China and Germany for an intracranial continuous infusion delivery device. The company stated the expanded protection spans therapeutic use claims, CNS delivery methods, device-enabled administration and broader oncology and neurology applications, forming an integrated commercialization platform intended to strengthen long-term defensibility, support strategic partnerships and enhance shareholder value, with additional data presentations planned at BIO-Europe Spring March 23—25, 2026.

To view the full press release, visit https://ibn.fm/YDX32

Oncotelic Therapeutics Inc. (OTCQB: OTLC) is a clinical-stage biopharmaceutical company developing RNA-based, immunotherapy, and targeted therapeutics for cancer and other underserved diseases. The company is focused on transforming outcomes for patients with difficult-to-treat and rare conditions, particularly pediatric cancers and aggressive solid tumors. Its development strategy centers on novel compound design, nanoparticle drug delivery, and the integration of artificial intelligence to accelerate discovery and regulatory workflows.

At the center of this foundation is Chairman and CEO Dr. Vuong Trieu, a prolific industry pioneer who has filed more than 500 patents with 75 issued patents across biologics, small molecules, nanoparticles, and diagnostics. Dr. Trieu co-invented Abraxane® (sold to Celgene for $2.9 billion), underscoring his track record of creating high-value therapies. Through collaborations with industry leaders and its stake in specialized joint ventures, Oncotelic is positioned to advance a diverse portfolio of oncology assets with greater speed and cost efficiency. The company also operates a proprietary AI platform, PDAOAI, which streamlines scientific writing, regulatory documentation, and data interpretation. This system is accessible to the public through a dedicated Discord server, offering real-time engagement with Oncotelic’s research ecosystem.

With expanded clinical activity and a next-generation development model, Oncotelic continues to evolve as a multi-asset innovator in precision oncology.

The company is headquartered in Agoura Hills, California.

Pipeline and Partnerships

Oncotelic’s lead candidate is OT-101, currently in a Phase 3 trial for pancreatic ductal adenocarcinoma (STOP-PC study) and evaluated in gliomas and metastatic solid tumors in combination with IL-2 and checkpoint inhibitors. The antisense molecule targets TGF-β2, a cytokine known to suppress immune responses and promote tumor growth. A Phase 1 trial combining OT-101 with IL-2 was recently completed, demonstrating safety and paving the way for combination therapies with PD-1 blockers and other immunotherapies.

Recent data have further strengthened the rationale for OT-101 in pancreatic ductal adenocarcinoma (PDAC). In June and July 2025, two peer-reviewed studies published in the International Journal of Molecular Sciences identified TGF-β2 gene expression and methylation status as significant prognostic markers in PDAC, particularly among younger patients and those with low CD8+ T-cell infiltration. High TGF-β2 expression correlated with reduced overall survival, while elevated TGF-β2 methylation was associated with improved outcomes. These findings validate TGF-β2 as a high-priority target and support the continued development of OT-101 as a precision therapy. Both studies leveraged Oncotelic’s proprietary AI-driven platform, PDAOAI, to mine and assemble multi-omic datasets, showcasing the system’s role in accelerating insight generation.

The company holds a 45% ownership stake in GMP Biotechnology Limited, a joint venture with Dragon Capital Overseas Limited. GMP Bio owns SAPU Bioscience, which is executing several pipeline programs. SAPU and Oncotelic are jointly utilizing a rapid IND platform through their partnership with Shanghai Medicilon to support regulatory filings for up to 20 drug candidates, with five INDs already underway. This collaboration is central to accelerating development of next-generation anticancer agents.

After the joint venture, Dr. Trieu, with his team, built out a state of the art and GMP-certified R&D facility in San Diego, which operates under SAPU, that manufactures clinical trial materials and supports a proprietary nanoparticle platform trademarked Deciparticle ™. This platform includes four therapeutic candidates—two of which are in late-stage manufacturing and expected to enter IND filing before the end of 2025.

Additionally, Oncotelic owns AL-101, an intranasal administered apomorphine product intended for the treatment of Parkinson’s disease, Erectile Dysfunction, and Female Sexual Disorders.

Market Opportunity

Oncotelic is targeting large and underserved therapeutic markets with significant commercial potentials. The global pancreatic cancer treatment market alone is projected to grow at a 12.3% CAGR, reaching $5.84 billion by 2030, up from $2.92 billion in 2024, according to Research and Markets. This growth is driven by increased disease prevalence, aging populations, and demand for more effective treatment options. Notably, the incidence of early-onset PDAC is rising at an estimated rate of 4% per year in the 15–34 age group, highlighting an emerging unmet need for targeted therapies among younger patients.

Beyond oncology, Oncotelic intends to develop AL-101 for Parkinson’s disease, which affects over 1 million patients in the U.S. alone and is expected to impact 1.2 million by 2030. Erectile Dysfunction and Female Sexual Dysfunction are also major global health issues, with Erectile Dysfunction affecting up to 70% of men over 60 and Female Sexual Dysfunction impacting approximately 40% of women—both with limited treatment options, particularly for patients who fail to respond to existing medications. These underserved populations offer fertile ground for innovative new therapies.

Leadership Team

Dr. Vuong Trieu is the Chairman and CEO of Oncotelic Inc. An accomplished innovator in pharmaceutical development, Dr. Trieu previously served as President and CEO of Igdrasol, where he pioneered the approval path for paclitaxel nanomedicine via a single bioequivalence trial. After Igdrasol merged with Sorrento Therapeutics, he became Chief Scientific Officer and a Board Director. He also held leadership roles at Cenomed, Abraxis, Applied Molecular Evolution, and Parker Hughes Institute. Dr. Trieu holds a Ph.D. in Molecular Microbiology, a B.S. in Botany, has published widely, and filed over 500 patent applications with 75 issued U.S. patents.

Amit Shah is the Chief Financial Officer of Oncotelic Inc. He has over 20 years of financial leadership in life sciences, including CFO roles at Marina Biotech and Igdrasol, and senior positions at ISTA Pharmaceuticals, Spectrum Pharmaceuticals, and Caraco. He also worked in consulting and ERP implementation. Mr. Shah holds a Bachelor of Commerce from the University of Mumbai, is an Associate Chartered Accountant in India, and is an inactive CPA in Colorado.

Dr. Anthony E. Maida III is the Chief Clinical Officer – Translational Medicine at Oncotelic Inc. He has over 25 years of experience advancing cancer immunotherapies and held senior roles at Northwest Biotherapeutics, PharmaNet, and Jenner Biotherapies. He has raised over $200 million for biotech firms and negotiated licensing deals with institutions such as Pfizer, Eli Lilly, and Yale. Dr. Maida holds dual B.A. degrees in Biology and History, an MBA, an M.A. in Toxicology, and a Ph.D. in Immunology, and is active in ASCO, AACR, and other scientific societies.

Oncotelic Therapeutics Inc. (OTCQB: OTLC), closed Thursday's trading session at $0.04895, up 8.7778%, on 343,721 volume. The average volume for the last 3 months is 103,892 and the stock's 52-week low/high is $0.64/$6.26.

Recent News

• Oncotelic Therapeutics Inc. (OTCQB: OTLC) - BioMedNewsBreaks - Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Expands Global Intellectual Property Portfolio Supporting OT-101 Across Neurology and CNS Delivery
• InvestorNewsBreaks - Oncotelic Therapeutics Inc. (OTLC) Advances Nanoparticle Drug Delivery, Prepares First-in-Human Study of IV Everolimus
• Oncotelic Therapeutics Inc. (OTLC) Unveils Breakthrough Nanomedicine Platform, Expands Everolimus (Afinitor(R)) Pipeline

Renewal Fuels Inc. (OTC: RNWF)

The QualityStocks Daily Newsletter would like to spotlight Renewal Fuels Inc. (OTC: RNWF).

Renewal Fuels (OTC: RNWF) announced the appointment of Dwight Cartwright as Chief Operating Officer and member of its Board of Directors, strengthening leadership as the company advances the Texatron(TM) fusion platform toward commercial deployment. Cartwright brings senior experience across operations, manufacturing, infrastructure development and large-scale, technology-driven organizations, and will oversee day-to-day operations, manufacturing and supply chain readiness, infrastructure buildout, safety and quality systems, and organizational execution. Leadership highlighted his operational discipline and experience scaling complex programs as critical to supporting American Fusion's next phase of growth and deployment.

To view the full press release, visit: https://ibn.fm/LpvEQ

Renewal Fuels Inc. (OTC: RNWF) (d/b/a American Fusion) is an advanced energy platform company focused on building a scalable, infrastructure-grade fusion energy business through its wholly owned subsidiary, Kepler Fusion Technologies. Following a completed reverse merger with Kepler, the company has repositioned itself around the development and long-term commercialization of deployable fusion power systems designed for real-world industrial and infrastructure use rather than experimental research programs.

The company’s strategy centers on pairing proprietary fusion technology with disciplined governance, intellectual property development, and a public-company operating framework intended to support long-duration value creation. Management has emphasized transparency, regulatory readiness, and institutional credibility as foundational elements alongside continued technical progress.

Renewal Fuels is in the process of transitioning its public identity to American Fusion to reflect its strategic focus on advanced fusion energy infrastructure and commercialization.

The company is based in Southlake, Texas.

Kepler Texatron™

Through wholly owned subsidiary, Kepler Fusion Technologies, the company is developing the Texatron™ aneutronic fusion platform, a compact, pulsed fusion system engineered specifically for commercial and infrastructure-grade deployment. Unlike steady-state fusion concepts that prioritize laboratory demonstration, the Texatron™ operates in controlled cycles designed to support modular scalability, redundancy, and distributed installation across multiple end markets.

The platform is optimized around a Deuterium–Helium-3 fuel pathway that enables direct electrical energy conversion, reducing reliance on traditional steam cycles and minimizing neutron-related material degradation. This design supports a smaller physical footprint and greater flexibility for deployment in grid-constrained or mission-critical environments such as data centers, industrial facilities, defense installations, and remote locations.

Kepler’s commercialization model is structured around a Power-as-a-Service approach under which the company intends to retain ownership of its fusion units and sell electricity to customers under long-term contractual arrangements. This infrastructure-oriented model is designed to align system deployment with predictable, recurring revenue while allowing for fleet-based scaling over time. The platform is supported by a broad and expanding intellectual property estate encompassing reactor architecture, energy conversion systems, control technologies, manufacturing processes, and deployment methodologies.

Market Opportunity

U.S. electricity demand has re-entered a period of sustained growth following nearly two decades of relative stagnation, according to data from the U.S. Energy Information Administration. After years in which efficiency gains and structural economic shifts largely offset population and economic growth, electricity consumption has increased meaningfully since 2020 and is forecast to continue rising through at least the middle of the decade.

Recent and projected growth is being driven primarily by the commercial and industrial sectors, with data centers, advanced manufacturing, and other power-intensive operations accounting for a disproportionate share of incremental demand. These segments tend to require continuous, non-intermittent electricity supply, placing increased pressure on existing generation and transmission infrastructure.

This shift underscores a growing need for reliable baseload power sources that can be deployed without extensive new transmission build-out and that align with emissions-reduction objectives. Fusion-based energy systems designed for distributed, infrastructure-grade deployment represent a potential long-term solution for meeting rising demand in environments where reliability, resilience, and scalability are critical.

Leadership Team

Richard Hawkins, Chairman and Chief Executive Officer, has overseen the company’s strategic reset, corporate restructuring, and transition toward an advanced fusion energy platform, with responsibility for governance, capital markets strategy, and long-term corporate development.

Brent Nelson, Chief Executive Officer of Kepler Fusion Technologies, brings extensive experience in energy systems and commercialization strategy and leads the development, validation, and deployment roadmap for the Texatron™ fusion platform, as well as Kepler’s intellectual property and operating model.

Renewal Fuels Inc. (OTC: RNWF), closed Thursday's trading session at $0.0225, up 2.2727%, on 11,788,744 volume. The average volume for the last 3 months is 335,519 and the stock's 52-week low/high is $0.6882/$5.64.

Recent News

• Renewal Fuels Inc. (OTC: RNWF) - GreenEnergyBreaks - Renewal Fuels, Inc. (OTC: RNWF) Appoints Dwight Cartwright as Chief Operating Officer and Director
• InvestorNewsBreaks - Renewal Fuels, Inc. (OTC: RNWF) Engages IBN to Lead Corporate Communications Strategy Following American Fusion Repositioning
• GreenEnergyBreaks - Renewal Fuels, Inc. (OTC: RNWF) Appoints Dr. John E. Brandenburg as CTO of Kepler Fusion Technologies

Xeriant Inc. (OTCQB: XERI)

The QualityStocks Daily Newsletter would like to spotlight Xeriant Inc. (OTCQB: XERI).

Xeriant (OTCQB: XERI) recently expanded the role of Brig. Gen. Blaine D. Holt (ret.), signaling a deeper commitment to disciplined innovation and advanced research. An article discussing this reads, "Holt's appointment to lead Factor X marked the beginning of his formal involvement with Xeriant and expanded his responsibilities beyond advisory into active leadership of the company's most forward-looking research initiatives. Xeriant recognized that Holt's experience advising senior military and government leaders brought a critical perspective to the evaluation and development of advanced technologies with both commercial and strategic relevance…From a governance perspective, Holt's involvement as the operational leader of Factor X reflects Xeriant's effort to tightly integrate strategic oversight with innovation execution. The company has framed this structure to reduce friction between vision and implementation, ensuring that advanced research efforts remain aligned with long-term corporate objectives… More broadly, Holt's increasing participation underscores Xeriant's intent to position itself at the intersection of advanced technology development and practical application."

To view the full article, visit https://ibn.fm/piiYb

Xeriant Inc. (OTCQB: XERI) is dedicated to the discovery, development and commercialization of emergent, transformative technologies, focusing on eco-friendly advanced materials with applications across multiple industries.

The company builds its technology portfolio through strategic partnerships, acquisitions, and internal development programs, emphasizing diversification and synergy, and is supported by its innovation platform called Factor X Research Group. Xeriant’s affiliated entities maintain operational focus and expertise while becoming part of a collaborative interdisciplinary innovation hub aimed at enhancing capabilities and accelerating technology development and deployment.

Xeriant’s advanced materials line is marketed under the DUREVER™ brand and includes NEXBOARD™, a patent-pending composite construction panel made from recycled plastic and fiber waste, designed to replace drywall, plywood, OSB, MDF, MgO board and other construction panels.

The company is headquartered in Boca Raton, Florida.

Portfolio

NEXBOARD™

Xeriant’s primary commercial focus is NEXBOARD™, an eco-friendly composite construction panel made from recycled plastic and fiber waste and enhanced with the company’s proprietary nanotechnology-based fire retardant, marketed under the DUREVER™ brand. Internal tests have demonstrated exceptional fire resistance, including a five-minute torch test reaching up to 2,500ºF and an 80-minute high-heat evaluation exceeding 2,000ºF.

The company has completed multiple limited production runs and internal tests to support certification, with accredited agencies documenting materials, processes, and quality controls. Upcoming certification testing includes NFPA 286 and ASTM E84, along with structural and durability testing.

Factor X Research Group

Factor X is Xeriant’s advanced innovation division, established to accelerate high-impact technologies from concept to commercial deployment. Modeled after Lockheed’s Skunk Works™, the group brings together experts across advanced materials, aerospace, artificial intelligence, critical infrastructure, and related disciplines to streamline development and strengthen cross-functional collaboration.

Its expanded mandate includes identifying acquisition opportunities; targeting disruptive technologies in areas such as AI, quantum computing, and data science; and supporting products like NEXBOARD™ as they move through the company’s commercialization pipeline.

Under the leadership of Brig. Gen. (Ret.) Blaine D. Holt, Factor X provides a coordinated environment designed to unify technical teams, reduce development barriers, and advance innovations with near-term market potential.

Market Opportunity

Xeriant operates at the intersection of several rapidly expanding sectors, including advanced aerospace systems, sustainable construction materials, and next-generation industrial technologies. Demand for eco-friendly building materials continues to accelerate, with the green construction market projected to reach $1.8 trillion by 2030, according to a World Economic Forum report, supported by rising global standards for safety, sustainability, and carbon reduction. NEXBOARD also participates in the broader fire-protection materials market, which is projected to grow from $37.69 billion in 2025 to $59.9 billion by 2034, according to Market Research Future, driven by stricter building codes and increasing awareness of fire-resistant alternatives.

Xeriant plans to capitalize on opportunities emerging from green construction, modular homebuilding, advanced composites engineering, nanotechnology, thermal-management innovations, and cross-disciplinary integration for new product development. Each prospective technology undergoes rigorous due diligence, including market forecasting, management evaluation, competitive assessment, and financial analysis, allowing Xeriant to pursue selective, strategically aligned acquisitions and partnerships.

Leadership Team

Keith F. Duffy, Chairman and Chief Executive Officer, has more than 30 years of experience across investment banking, finance, strategic planning, and operations, and has served as a principal in multiple start-ups spanning aviation, software, banking, and biotech. He arranged the merger that created Xeriant, established the company’s partnership with Florida Atlantic University, and previously held roles ranging from securities broker to controller of an aviation FBO. He is a licensed real estate and mortgage professional and holds a B.A. in Business Administration and Mathematics from Rollins College.

Scott M. Duffy, Executive Director of Corporate Operations, has built a career of over 30 years in management, operations, strategic planning, IT, marketing, and distribution, including oversight of a $545 million retail sales division at American Media. He has collaborated on business development efforts for several start-ups, including Xeriant, and has held senior roles supporting large-scale operational and administrative functions. He earned a B.A. in Business Administration and Mathematics from Rollins College.

Pablo Lavigna, Chief Information Officer, has more than 20 years of experience in information technology and software engineering, supporting Xeriant through technology sourcing, internal systems management, and the development of security and software solutions. His background includes directing IT operations for private firms and implementing network security and specialized software tools across multiple industries. He holds Microsoft and CompTIA certifications and graduated magna cum laude from Florida International University with a degree in Information Technology and Business.

Brian Carey, Chief Financial Officer, has spent over 30 years in accounting, tax, financial management, and business development, having founded and operated a long-standing accounting and advisory firm serving start-ups and established companies. His experience includes business planning, financial oversight, and operational support for partner organizations. He holds a Bachelor of Accounting degree from Penn State University.

Brig. Gen. (Ret.) Blaine D. Holt, President of Factor X Research Group, has a distinguished background in multinational operations, aerospace leadership, and technology-driven enterprise, including service as Deputy U.S. Military Representative to NATO and as a command pilot with more than 3,900 flight hours. His experience spans advanced manufacturing, AI-enabled logistics, large-scale aviation turnarounds, and advisory work supporting emerging technologies, strengthening Xeriant’s ability to evaluate and advance high-impact innovations.

Xeriant Inc. (OTCQB: XERI), closed Thursday's trading session at $0.0089, even for the day, on 150,710 volume. The average volume for the last 3 months is 74,783,137 and the stock's 52-week low/high is $0.2512/$4.1.

Recent News

• Xeriant Inc. (OTCQB: XERI) - InvestorNewsBreaks -Xeriant Inc. (XERI) Positions Factor X at Forefront of Advanced Research Under Brig. Gen. Holt
• Xeriant Inc. (XERI) Builds Innovation Ecosystem Focused on Advanced Technologies, Commercialization
• NetworkNewsBreaks - Xeriant Inc. (XERI) Building Momentum in Advanced Materials with NEXBOARD(TM)

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT).

HeartBeam was included in a report published by Modern Healthcare that highlighted companies that achieved meaningful regulatory milestones or demonstrated forward momentum.

HeartBeam's technology is aligned with evolving regulatory and clinical priorities.

In addition to being listed in the Modern Healthcare report, the company was also included in PatentVest's "Total Cardiac Intelligence" report.

HeartBeam (NASDAQ: BEAT) was recently recognized among a select group of medical device companies featured in a January industry roundup highlighting recent U.S. Food and Drug Administration ("FDA") clearances and approvals across the sector. The recognition underscores HeartBeam's progress as it advances a novel approach to cardiac diagnostics through its HeartBeam System, a cable-free, high-fidelity ECG platform designed to capture the heart's electrical signals from three distinct directions and synthesize them into a 12-lead ECG for arrhythmia assessment.

HeartBeam Inc. (NASDAQ: BEAT) is a medical technology company pioneering a new approach to cardiac care by delivering hospital-grade electrocardiogram (ECG) insights outside traditional clinical settings. Its proprietary platform supports a scalable app-based solution for real-time heart monitoring.

The company’s mission is to empower both patients and physicians with actionable cardiac data wherever symptoms begin, addressing a critical gap in the first hours of cardiac events. Through its connected cardiac care ecosystem, HeartBeam is establishing a new model for remote monitoring that deepens patient engagement and delivers more actionable insights for physicians. This approach is designed to obtain early diagnosis which could reduce time to treatment, improve outcomes, and lower costs across the healthcare continuum.

HeartBeam’s system aims to bring clinical-grade cardiac assessment into the home. HeartBeam is preparing for commercial launch as its 12-lead ECG synthesis software undergoes regulatory review, building on prior clearance of its 3D ECG system for arrhythmia assessment. The company plans to leverage its unique longitudinal ECG dataset and deep learning algorithms to advance predictive capabilities in the future.

HeartBeam is headquartered in Santa Clara, California.

Products

HeartBeam’s flagship innovation is its credit card-sized, cable-free ECG device that collects heart signals in three non-coplanar dimensions and synthesizes a 12-lead ECG. Cleared by the FDA in December 2024 for arrhythmia assessment, the HeartBeam System enables patients to capture high-fidelity heart data during symptomatic episodes, even outside a clinical environment.

The company’s pending 12-lead ECG synthesis software, developed from the same 3D signal acquisition, successfully met clinical endpoints in the VALID-ECG study and is currently under FDA review for arrhythmia assessment. This software combined with an on-demand cardiologist reader service is expected to form the backbone of HeartBeam’s commercial launch strategy, providing patients with access to a synthesized 12-lead ECG outside of the traditional hospital setting and enabling physician interpretation of patient ECGs from anywhere.

From the core, the team is building an ecosystem that includes integration with wearables, automated arrhythmia assessments, AI-driven wellness features, community features and trending insights. The ecosystem is intended to drive adoption and increase the overall value of the HeartBeam System.

Artificial Intelligence and Predictive Analytics

To enhance its diagnostic capabilities, HeartBeam is developing AI-powered arrhythmia detection algorithms to be validated in collaboration with Mount Sinai Heart. In early testing, these deep learning algorithms achieved diagnostic accuracy comparable to standard 12-lead ECGs when classifying atrial fibrillation, atrial flutter, and sinus rhythm.

Additionally, HeartBeam’s AI engine has the potential to transform routine monitoring into predictive power in the future. The company’s platform enables frequent readings, building a unique longitudinal ECG dataset unique that no one else offers. By leveraging deep learning on the repeated measurements, there is an opportunity to develop predictive capabilities, such as screening for hidden cardiac conditions and forecasting risk of future events. The unique longitudinal dataset will create a defensible data moat as the company continues to advance its AI program.

Market Opportunity

HeartBeam is targeting a large unmet need in cardiac care by delivering hospital-grade ECG diagnostics to patients outside of traditional healthcare settings. Cardiovascular disease is the leading cause of death worldwide, yet most cardiac events occur at home, where standard 12-lead ECGs are not available, leading to costly delays in diagnosis and treatment. HeartBeam’s FDA-cleared 3D ECG technology is designed to close this critical gap with on-demand, remote diagnostic capabilities.

The company’s initial commercialization strategy focuses on two distinct U.S. entry markets. The first includes approximately 500,000 elevated-risk patients in concierge care settings, representing a $250 million to $500 million annual revenue opportunity. The second addresses a larger direct-pay segment of 2.6 million elevated-risk individuals, with potential revenues of $1.3 billion to $2.6 billion annually. Future expansion may include reimbursement-driven pathways through Medicare Advantage, providers, and payer partnerships.

HeartBeam anticipates annual subscription pricing between $500 and $1,000 per patient, with roughly 50% gross margins on device costs and 70%+ on recurring revenue. Based on a model using five U.S. regions, each with an estimated 75,000 eligible patients, HeartBeam projects that just 10% adoption would generate approximately $20 million in gross profit—enough to reach cash flow break-even under current pricing and margin assumptions. Over time, the company’s longitudinal ECG dataset and predictive AI capabilities are expected to deliver additional value to healthcare systems, research institutions, and life science partners.

Leadership Team

Robert Eno, Chief Executive Officer and Director, brings over 30 years of experience in the medical technology industry, including leadership roles at HeartFlow, OptiMedica, and NeoGuide Systems. He joined HeartBeam as President in January 2023 and was appointed CEO in October 2024, later joining the board in May 2025 to support commercial growth.

Branislav Vajdic, Ph.D., Founder and Chief Technology Officer, is a semiconductor and medtech innovator who previously led product design teams at Intel and founded NewCardio. He holds over 20 patents and is the original architect of HeartBeam’s core technology.

Tim Cruickshank, Chief Financial Officer, oversees financial strategy and capital allocation. He works closely with the leadership team to support commercialization while maintaining financial discipline aligned with key regulatory milestones.

Peter Fitzgerald, M.D., Ph.D., Chief Medical Advisor, is Director of the Center for Cardiovascular Technology at Stanford and a seasoned clinical trialist with over 175 studies and 650 publications. He has founded over 20 medtech companies and advises the FDA on digital health analytics.

Ken Persen, Chief Technology Officer, has more than 28 years of experience in cardiac rhythm management and digital health. He previously served as CTO and CEO at LIVMOR and held engineering roles at Cameron Health and Guidant.

HeartBeam Inc. (NASDAQ: BEAT), closed Thursday's trading session at $1.22, off by 7.5758%, on 441,541 volume. The average volume for the last 3 months is 12,699,260 and the stock's 52-week low/high is $0.000001/$0.0421.

Recent News

• HeartBeam Inc. (NASDAQ: BEAT) - HeartBeam Inc. (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year
• BioMedNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer 
• BioMedNewsBreaks - FDA Clearance for HeartBeam Inc. (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup

Soligenix Inc. (NASDAQ: SNGX)

The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).

Soligenix (NASDAQ: SNGX) issued a shareholder update from President and CEO Dr. Christopher J. Schaber outlining anticipated 2026 milestones across its late-stage rare disease pipeline, including top-line data from the Phase 3 FLASH2 trial of HyBryte in early-stage cutaneous T-cell lymphoma expected in the second half of 2026, with an interim analysis approaching in the second quarter and 66 of 80 patients enrolled as of Feb. 10. The letter also reviewed positive Phase 2a data for SGX945 (dusquetide) in Behçet's Disease published in Rheumatology (Oxford), encouraging Phase 2a psoriasis results for SGX302, ongoing strategic evaluations including partnership and M&A opportunities, and the company's cash position of approximately $10.5 million as of Sept. 30, 2025, with runway projected through 2026.

To view the full press release, visit https://ibn.fm/oFisl

Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.

The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.

With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.

The company is headquartered in Princeton, New Jersey.

Pipeline and Development Programs

Specialized BioTherapeutics

Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.

SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.

SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.

Public Health Solutions

The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.

The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.

The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.

Market Opportunity

Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.

SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.

In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.

Leadership Team

Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.

Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.

Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.

Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.

Soligenix Inc. (NASDAQ: SNGX), closed Thursday's trading session at $1.06, off by 1.8519%, on 130,833 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0/$0.

Recent News

• Soligenix Inc. (NASDAQ: SNGX) - BioMedNewsBreaks - Soligenix Inc. (NASDAQ: SNGX) CEO Highlights 2026 Clinical Milestones and Strategic Options
• Soligenix Inc. (NASDAQ: SNGX) Driving Innovation in Photodynamic Therapy Potential in Oncology, Dermatology
• NetworkNewsBreaks - Soligenix Inc.'s (NASDAQ: SNGX) SGX945 Shows Promise with Immune-Modulating Approach

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)

The QualityStocks Daily Newsletter would like to spotlight ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

ESGold Corp., a development-stage mining company, just added 144 new mining claims in and around its Montauban project in Quebec

The expansion follows the recent completion of an ANT-based 3D geological model, suggesting the potential for a mineralized corridor extending approximately 900 meters in depth and over two kilometers of strike

The expansion allows ESGold to systematically and strategically evaluate the full extent of the Montauban mineral system, marking a critical inflection point for the company, with evaluation that is no longer constrained by historical evaluations

ESGold (CSE: ESAU) (OTCQB: ESAUF) , a development-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, just added 144 new mining claims in and around its Montauban project, bringing the total to 417 mining claims. This milestone represents the largest contiguous mineral tenure held by a single company in the region. The move also ensures that the company is not constrained by historical boundaries that previously limited its operations ( https://ibn.fm/bXFk9 ).

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is a fully permitted, pre-production resource company on a clear path to near-term gold and silver production. With established infrastructure in place and a significant gold-silver resource, the company is uniquely positioned to generate near-term cash flow while unlocking the full potential of its Montauban Gold-Silver Project in Quebec—one of the top mining jurisdictions in the world.

ESGold is building a foundation for long-term growth through a dual-track strategy: cash-flow generation from tailings reprocessing to fund district-scale exploration.

The Montauban site, which operated as a mine for over 80 years, is now undergoing its first-ever systematic exploration program to determine just how large the remaining deposit may be. Near-term cash flow from tailings reprocessing will be used to fund exploration, with the goal of increasing the resource base and uncovering new discoveries across the expansive land package.

ESGold is advancing a scalable and replicable clean extraction model that turns legacy mine sites into revenue generating assets while setting a new industry benchmark for sustainable resource recovery.

The recent completion of a C$3.4M financing has enabled ESGold to initiate the final construction phase of its mill circuit—moving the company decisively toward production of gold and silver in Q3 2025.

Montauban Gold-Silver Project: Production Imminent

Located approximately 80 kilometers west of Quebec City, the Montauban Project is a past-producing gold-silver mine with surface and underground mineralization and over 900,000 tonnes of historical tailings. ESGold has invested over C$15 million to date, building out roads, power access, and a 16,000 sq. ft. processing facility. The company recently completed a C$3.4M financing to begin final construction of the mill circuit.

The company is fully permitted to enter into production that is expected to commence in Q3 2025 with a capacity of 500 tonnes per day, scaling to 1,000 tpd. An updated Preliminary Economic Assessment (PEA) is currently underway to reflect all-time high gold prices and the anticipated upside from the near-surface resource.

Parallels Between Broken Hill & Montauban

Broken Hill, discovered in 1883 in Australia, became the world’s largest source of silver, lead, and zinc—producing over $100 billion worth of metals. What made it unique was that the richest mineral zones were hidden deep underground in a twisted, boomerang-like shape, and it took decades to fully understand just how large the deposit really was.

Geologists now believe ESGold’s Montauban Project in Quebec may share similar traits. Like Broken Hill, it contains high-grade silver, lead, and zinc, along with gold—and sits within the same type of geological system known to host large, high-value mineral deposits. The rock formations, mineral assemblages, and structural complexity all suggest that Montauban could be hiding much more than what’s been historically uncovered. Academic studies now support this possible geological parallel, pointing to further evidence suggesting Montauban was formed under similar conditions as Broken Hill.

Exploration Upside

With production on the horizon, ESGold is advancing a major exploration campaign. Montauban has never undergone systematic modern exploration.

The company is currently completing a large-scale Ambient Noise Tomography (ANT) survey—a powerful 3D imaging technology that will define the size, shape, and continuity of the mineralized system. ANT is already showing strong results, with imaging going beyond the original 400m depth target and now expected to exceed 800m. This cutting-edge technology has the potential to reveal the full extent of the anomaly for the first time in Montauban’s 110-year history.

Scalable, Replicable, Clean Mining

Montauban is also part of a broader vision. Across Canada and globally, there are hundreds of orphaned or legacy mine sites that remain unrehabilitated despite containing valuable residual metals in tailings. Quebec alone is home to more than 259 of these sites, highlighting the scale of the opportunity. ESGold is advancing a scalable and replicable clean extraction model that transforms legacy sites into productive assets while setting a new benchmark for sustainable resource recovery.

The company has also performed testing that utilizes Dundee Sustainable Technologies’ CLEVR Process™, a proprietary non-cyanide extraction method that achieved 90.9% gold recovery in lab testing. This clean processing approach remains a valuable and scalable asset supporting ESGold’s near-term production and exploration growth strategy.

As a complement to its core mining operations, ESGold is developing clean technology solutions through a joint venture with DMCMS Inc. This initiative includes a polymer division that manufactures environmentally friendly products such as road stabilizers, dust suppressants, and other industrial blends—expanding the company’s sustainable commercial footprint.

Market Opportunity

ESGold is operating in a unique and specialized segment of the mining industry—reprocessing and revitalizing legacy mine sites. The Montauban Project offers both near-term cash flow and long-term growth potential by converting tailings into revenue while systematically exploring for additional high-value mineral endowments. The company’s established infrastructure, full permitting, and reclamation approvals reduce development risk and enhance execution timelines.

The broader green mining market is projected to reach $15.92 billion by 2030, according to Grand View Research. This growth is being driven by increased demand for responsible extraction methods, ESG-aligned practices, and critical mineral security. With construction underway at its fully permitted Montauban site—and exploration advancing along a Broken Hill-type geological model—ESGold is well positioned to emerge as Canada’s next premier gold and silver producer.

Leadership Team

Paul Mastantuono, Chief Executive Officer and Director, graduated with distinction from the University of Ottawa with a bachelor’s degree in social science, concentrating in criminology. He has extensive experience in the construction and transportation industries and has worked as an independent business consultant for various companies, including DNA Precious Metals Inc.

Brad Kitchen, President and Director, brings over 35 years of experience in investment banking and senior corporate management, primarily with resource-based companies. He has a detailed knowledge of regulatory, security, and tax issues, cross-border financings, and market influences, which he has applied to address business challenges for issuers and investors. Mr. Kitchen was also CEO of Eagle Hill Exploration, the company that generated in only five years the first Bankable Feasibility Study on the Windfall Lake Gold Project that was recently sold by Osisko Mining to Gold Fields for US$1.6 billion.

Andre Gautier, Senior Geologist and Director, brings over 47 years of experience in the Mining Exploration field and has worked in over 35 countries. His work experience includes entities such as: SOQUEM, Falconbridge Ltd., Noramco and Cambior Inc. Mr. Gauthier was president of MaxyGold Corp. (China), INCA Pacific Resources Inc., Lara Exploration Ltd., and Gold Holding Ltd. Mr. Gauthier also served as a Director of Vena Resources Inc., MaxyGold Corp., Lara Exploration Ltd., Western Union Peru, and Gold Holding Ltd., and from March 2015 until 2018, he served as interim Managing Director and CEO of Gold Holding Ltd., headquartered in Dubai (UAE). He has a BSC in Geology Eng. and MSC from UQAC (Chicoutimi, Quebec) and is an active member and leader of many mining and professional organizations (Canada, Peru, UAE, and China).

ESGold Corp. (OTCQB: ESAUF), closed Thursday's trading session at $0.540675, off by 0.793578%, on 97,066 volume. The average volume for the last 3 months is 35,596,634 and the stock's 52-week low/high is $4.45/$46.75.

Recent News

• ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Adds 144 Mining Claims for Mountauban Project After 3D Geological Model Points to Greater Potential
• ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Marks Pivotal Milestone with Completed and Delivered Comprehensive ANT-Based 3D Geological Model for Montauban
• RockBreaks - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Expands Montauban Land Position With 144 Newly Staked Claims in Québec

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF)

The QualityStocks Daily Newsletter would like to spotlight Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF).

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Powermax released Phase 2 stream sediment assay results from its Cameron Rare Earth Element Project in British Columbia, showing elevated light, heavy, and total rare earth oxides, across multiple drainage catchments.

Results point to potential upstream bedrock sources and define priority areas for follow-up exploration.

The company plans to integrate these findings with pending soil and rock sample data.

Powermax is advancing a portfolio of REE assets in Canada and the U.S., including projects in Ontario and Wyoming.

Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF) , a Canadian mineral exploration company, recently reported new assay results from its Phase 2 stream sediment sampling program at the Cameron Rare Earth Element ("REE") Project in British Columbia, outlining a series of anomalous rare earth values that management says will help refine exploration targets ( https://ibn.fm/Ogebu ).

Disseminated on behalf of Powermax Minerals Inc., may include paid advertisements.

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) is a Canadian mineral exploration company developing a portfolio of rare earth element (“REE”) projects across Tier-1 jurisdictions in Canada and the United States. Focused on discovery, responsible advancement, and alignment with North America’s critical-minerals strategy, the company targets areas with geological potential for REE-bearing pegmatites and granitic systems.

Its exploration model emphasizes modern geophysics, data integration, and systematic de-risking through technical work. By concentrating on projects with clear infrastructure advantages and policy support, Powermax seeks to contribute meaningfully to regional supply-chain independence in critical minerals vital to electrification and advanced manufacturing.

The company’s growing asset base includes four core REE projects, Atikokan, Cameron, Pinard and Ogden Bear Lodge, positioned within highly prospective geological corridors.

Powermax Minerals is headquartered in Toronto, Ontario.

Projects

Atikokan REE Project – Northwestern Ontario

Powermax’s flagship Atikokan Rare Earth Element Project covers 9,416 hectares across three mineral claim blocks (A, B, and C) approximately 35 kilometers northwest of the town of Atikokan in the Thunder Bay Mining District. Located along the White Otter–Dashwa corridor, the project hosts REE-enriched granitic and pegmatitic systems supported by strong radiometric and geochemical signatures.

In 2025, Powermax completed airborne magnetic and gamma-ray spectrometric surveys, geological mapping, and geochemical sampling. An integrated interpretation released in November 2025 outlined a structural–geochemical corridor of REE enrichment, with Total Rare Earth Element (TREE) values from 254 ppm to 1,947 ppm across Blocks B and C. The company is currently advancing surface validation and target ranking for follow-up work.

Cameron REE Project – British Columbia

The Cameron Project, which the company holds an option to acquire, is located about 30 kilometers south of Revelstoke in the Kamloops Mining Division and comprises three contiguous mineral claims totaling 2,984 hectares.

Hosted within the Monashee Group, the property contains NYF-type granitic pegmatites and gneissic units known to carry both light and heavy REEs. Phase 1 exploration, completed under NI 43-101 recommendations, produced TREE values ranging from 17 ppm to 1,943 ppm, with heavy mineral concentrate samples up to 7,561 ppm. These findings confirmed consistent REE enrichment and led to the launch of Phase 2 exploration in October 2025 to expand mapping and refine drill targets.

Ogden Bear Lodge REE Project – Wyoming, USA

Powermax owns a 100% interest in the Ogden Bear Lodge Project, covering 22 lode claims (184 hectares) in Crook County, Wyoming. The property is prospective for high-grade neodymium-praseodymium (Nd/Pr) oxide mineralization and shares a border with Rare Element Resources’ Bear Lodge Critical Rare Earth Project. That neighboring project has received $24.2 million in U.S. Department of Energy support and a non-binding EXIM Bank letter of interest for up to $553 million in debt financing, highlighting the strategic value of this emerging U.S. REE district.

Pinard Rare Earths Project – Northern Ontario

In November 2025, Powermax Minerals announced plans to acquire a 100% interest in the Pinard Rare Earths Project, located roughly 70 kilometers north-northeast of Kapuskasing, Ontario. The property consists of 255 contiguous claims totaling 5,178 hectares within the Pinard Intrusive Rock Complex, an alkaline igneous system characterized by nepheline syenites and peralkaline granites commonly associated with REE-bearing mineralization.

Market Opportunity

Global demand for rare earth elements is projected to triple—from 59,000 tonnes in 2022 to 176,000 tonnes by 2035—driven by rapid electric-vehicle adoption and wind-power expansion, with supply expected to lag by up to 30%. The global REE market, valued at $3.95 billion in 2024, is forecast to reach $6.3 billion by 2030 at a compound annual growth rate of approximately 8.6%, according to Grand View Research.

China currently controls approximately 60% of REE mining and about 90% of processing capacity, prompting North American governments to accelerate domestic development. In 2025, the U.S. Department of Energy announced $1 billion in critical-minerals funding opportunities, while Canada’s C$1.5 billion Critical Minerals Infrastructure Fund supports projects through 2030. Together, this policy support and structural supply deficit highlight Powermax’s positioning within a strategically essential market tied to the clean-energy transition.

Leadership Team

Paul Gorman, CEO & Director, is a resource-based corporate specialist with more than 25 years of experience in junior mining finance, public listings, and corporate development. He is the President and Managing Partner of Riverbank Capital Inc., where he has raised over $150 million for emerging issuers and helped revitalize the North American graphite industry through the founding of Mega Graphite Inc. Gorman has led multiple exploration programs and was instrumental in achieving high-grade lithium discoveries in 2024 for Pan American Energy Corp.

Michael Malana, Director, has more than 20 years of international experience in financial management, reporting, and corporate governance. He has held senior executive roles across natural resources, biotechnology, and manufacturing and holds a Bachelor of Commerce degree from Concordia University in Montreal. Malana is a Chartered Professional Accountant (Certified Management Accountant).

Afzaal Pirzada, M.Sc., P.Geo., Director, is a professional geoscientist with over 30 years of experience in mineral exploration and mining, specializing in gold, lithium, graphite, rare metals, and uranium. He has served as Project Geologist, VP Exploration, Director, and CEO for multiple mining companies, including Adriana Resources and Rock Tech Lithium. Pirzada is a registered Professional Geoscientist with Engineers and Geoscientists British Columbia and has authored numerous NI 43-101 technical reports.

Powermax Minerals Inc. (OTCQB: PWMXF), closed Thursday's trading session at $0.4086, off by 6.462%, on 428,769 volume. The average volume for the last 3 months is 292,743 and the stock's 52-week low/high is $3.66/$29.571.

Recent News

• Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Reports Elevated Rare Earth Anomalies in Phase 2 Sampling at Cameron Project
• MiningNewsBreaks - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) Expands Atikokan REE Project With Acquisition of Contiguous Claims
• RockBreaks - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) Reports Anomalous REE Values From Phase 2 Stream Sediment Sampling at Cameron Project

Perpetuals.com Ltd. (NASDAQ: PDC)

The QualityStocks Daily Newsletter would like to spotlight Perpetuals.com Ltd. (NASDAQ: PDC).

Perpetuals.com Ltd. (NASDAQ: PDC) is a publicly traded, regulated digital market infrastructure company enabling derivatives trading through a compliant, API-driven platform. Built as infrastructure rather than a balance-sheet exchange, the company provides brokers, institutions, and trading venues with regulated access to crypto and tokenized derivatives while avoiding custody, credit, and counterparty exposure by design.

The platform addresses a structural gap created as demand for leveraged digital asset exposure has outpaced the availability of compliant market infrastructure, particularly in Europe. Regulatory constraints limit how traditional brokers can legally offer crypto leverage, while many existing trading venues operate outside regulated frameworks. Perpetuals is designed to function within these constraints by combining institutional-grade execution, real-time settlement, and structured product capabilities under an EU-regulated market framework.

By operating as a regulated trading venue and infrastructure provider, Perpetuals enables market participants to access derivatives through transparent and auditable systems rather than offshore or unregulated alternatives.

Platform & Infrastructure

Perpetuals operates a regulated hybrid exchange built on proprietary infrastructure and structured around an EU Multilateral Trading Facility (MTF) framework. The platform is designed as institutional trading infrastructure, incorporating a high-speed matching engine, real-time settlement, built-in compliance and surveillance, and a hybrid architecture that delivers centralized exchange performance with blockchain-based transparency.

The platform is API-native by design, enabling direct integration with CFD brokers, institutional counterparties, and trading venues. Through turnkey APIs, partners can integrate order routing, execution, structured product issuance, market data, settlement, risk management, and compliance reporting, while the platform is designed to avoid custody of client assets and balance-sheet exposure. This infrastructure-first model allows Perpetuals to function as a regulated trading venue rather than a trading counterparty.

On top of this infrastructure, the platform is designed to support crypto spot trading, perpetual futures, futures, options, swaps, and tokenized structured products, including regulated knock-out instruments intended to operate within European regulatory constraints. Perpetuals also incorporates a prediction and insight engine designed to reward accurate market signals while generating datasets used to refine pricing, risk parameters, and trading intelligence across its structured products.

Market Opportunity

Perpetuals operates at the intersection of several large and converging markets, including crypto derivatives, regulated trading infrastructure, CFD brokerage technology, and tokenized financial products. The global crypto perpetual futures market processes approximately $2.18 trillion in monthly trading volume, while Europe’s CFD market generates roughly $17.34 trillion in monthly notional volume from approximately 4.9 million active retail accounts.

European regulatory frameworks restrict CFD brokers from legally offering high-leverage crypto products, creating a significant gap between trader demand and compliant market access. As a result, demand for crypto leverage has outpaced the availability of regulated infrastructure capable of serving brokers and institutional participants. This dynamic has left a large segment of retail and professional trading activity without compliant, onshore solutions.

Perpetuals addresses this gap by enabling regulated knock-out and structured products that allow leveraged crypto exposure without breaching leverage caps. In parallel, the emergence and adoption of tokenized financial instruments and real-world assets have increased demand for compliant, multi-asset trading venues. By operating within a regulated MTF framework and supporting tokenized issuance and trading, Perpetuals enables participation in the ongoing institutional adoption of digital asset markets without reliance on offshore or unregulated systems.

Leadership Team

Patrick Gruhn is an entrepreneur, lawyer, software engineer, and fintech innovator with more than two decades of experience across technology, law, and financial markets in Europe and the United States. He has founded and scaled multiple technology companies spanning tokenized securities, legal technology, and digital infrastructure, including businesses later acquired by major industry participants. His work focuses on the intersection of blockchain, regulation, and artificial intelligence. Gruhn is also actively involved in academic and institutional initiatives related to digital innovation.

Robin Matzke is a legal and regulatory specialist with deep expertise in digital securities, tokenization, and market structure. He has founded and advised companies operating at the intersection of law and financial technology and has contributed to the development of legal frameworks for digital assets in Europe. His background includes doctoral research on virtual stock structures and extensive academic teaching and publication. Matzke has also served as an advisor on digital securities regulation at the legislative level.

Nayia Ziourti is a regulatory lawyer with more than 15 years of experience in European financial services regulation, compliance strategy, and governance. She has held senior legal and regulatory roles across both public authorities and private financial institutions, including leadership positions within EU-regulated digital asset entities. Her experience includes direct involvement with EU policy development, ESMA initiatives, and MiFID-related regulatory frameworks. Ziourti brings deep institutional knowledge of compliance implementation across complex jurisdictions.

Sean Prescott is a technologist and financial infrastructure architect with over 20 years of experience spanning fintech, cybersecurity, encryption, and decentralized systems. His background includes designing institutional trading infrastructure, secure settlement systems, and large-scale financial platforms across Europe, the Middle East, and North America. He has developed proprietary transaction and custody architectures used by governments, enterprises, and digital asset platforms. Prescott’s focus is on building secure, scalable infrastructure for regulated digital finance.

Stephen Stephens is a senior operations and technology executive with extensive experience scaling complex fintech, regtech, and enterprise platforms. His career includes leading global delivery teams, managing multimillion-dollar programs, and transitioning advanced technologies into stable operating environments. He brings expertise in operational execution, platform integration, and enterprise process management across regulated industries. Stephens has overseen large-scale implementations spanning trading systems, ERP platforms, and compliance-driven operations.

Aaron Rudder is a finance and economics professional focused on developing fairer and more efficient capital markets through regulated digital infrastructure. He brings experience across crypto finance, derivatives research, and tokenized market structures, including work within EU-regulated trading environments. Rudder has led research initiatives supporting compliant derivatives issuance and structured digital asset products. His background combines financial modeling, market analysis, and applied research at the intersection of regulation and emerging financial systems.

Perpetuals.com Ltd. (NASDAQ: PDC), closed Thursday's trading session at $4.96, up 16.1593%, on 50,464 volume. The average volume for the last 3 months is 66,653 and the stock's 52-week low/high is $3.63/$114.

Recent News

• Perpetuals.com Ltd. (NASDAQ: PDC) - Perpetuals.com Ltd. (NASDAQ: PDC) Completes BayesShield(TM) AI Pilot, Reporting 92% Block Rate on Losing Retail Crypto Trades
• Perpetuals.com Ltd. (NASDAQ: PDC) Targets the Regulated Bridge Between Traditional Markets and Blockchain Infrastructure
• CryptoNewsBreaks - Perpetuals.com Ltd (NASDAQ: PDC) Launches Barrier Futures Targeting Multi-Hundred-Trillion Derivatives Markets

MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF)

The QualityStocks Daily Newsletter would like to spotlight MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF).

MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) is a Canadian mineral exploration company pioneering the development of natural hydrogen as a potential new primary energy source. As a first mover in this emerging sector, the company has assembled North America’s largest permitted land package targeting naturally occurring, emissions-free hydrogen accumulations in the earth’s subsurface.

MAX Power plans to commence Canada’s first dedicated deep drilling program for natural hydrogen in November 2025, starting on the 200-km-long Genesis Trend in southern Saskatchewan, with the goal of converting a discovery into the world’s first commercial natural hydrogen venture in 2026.

Backed by institutional partnerships and a highly experienced technical team, MAX Power continues to build a globally recognized brand in the natural hydrogen sector. Its massive land package in Saskatchewan currently comprises 1.3 million permitted acres with another 5.7 million acres under application.

Saskatchewan, a jurisdiction recognized for its supportive regulatory environment and clean energy innovation, features North America’s most advanced policy framework for the exploration and development of natural hydrogen. The province is also known for its spectacular resource endowment as the world’s leading potash provider, the top high-grade uranium producer in the world, and Canada’s second-largest oil producer. Saskatchewan is also Canada’s leader in helium production, geothermal energy and carbon capture.

The company’s head offices are in Saskatchewan’s two largest cities, Saskatoon and Regina.

Projects

Natural Hydrogen (Saskatchewan)

MAX Power holds multiple large land packages across Saskatchewan prospective for deposits of natural hydrogen, highlighted by the 200-km-long Genesis Trend and the 75-km-wide Grasslands Project.

Genesis features easy road, rail and power access and a proposed hydrogen hub on its eastern side where there is an abundance of potential end-users for natural hydrogen. Drilling is set to begin in early November 2025 at the Lawson target situated in the heart of Genesis. Canada’s first deep well for natural hydrogen is specifically designed to test a complete five-element hydrogen system interpreted to exist at Lawson: source rocks, migration pathways, reservoirs, seals, and traps. Data from vintage and proprietary 2D seismic, gravity and magnetic surveys, and subsurface mapping, among other geological and geophysical information, support the prospectivity of Lawson which lies adjacent to an extensive regional “Salt Barrier” offering excellent seal and trap conditions.

The Genesis Trend’s scalability is further demonstrated by the recent identification of the Lucky Lake target, approximately 50 km northwest of Lawson and one of at least 20 Lawson “look-a-likes” that is being investigated along the trend. Early interpretation suggests serpentinized rocks and structural features favorable for hydrogen generation exist at Lucky Lake.

At Grasslands, geologists are excited about a broad area in the vicinity of a well (“Climax”) near the U.S. border that was drilled a few years ago and inadvertently resulted in Canada’s first known deep subsurface occurrence of natural hydrogen, associated with a rare rock assemblage geologists refer to as “exotic terrane”. Permits covering an area stretching 75 km east-west and up to 10 km north-south were acquired by MAX Power next to this discovery, amplifying the company’s first-mover advantage. Adjacent to three sides of Grasslands are producing helium wells owned by privately-held North American Helium, demonstrating that this under-explored area of the province is highly prospective for clean gas. Drilling of a target at Grasslands is expected during Q1 2026.

Other MAX Power land packages are Rider 1, 2 and 3 in the southeast part of the province, and Choiceland in the north-central part of the province.

To enhance scientific rigor and accelerate development, MAX Power has established a multi-year strategic collaboration with the Petroleum Technology Research Centre (PTRC), a globally recognized leader in subsurface energy research based in Regina, Saskatchewan. This partnership complements the company’s relocation to Innovation Saskatchewan’s R+T Parks in Saskatoon and Regina, placing its technical and executive teams at the heart of the province’s academic, regulatory, and infrastructure ecosystem.

Critical Minerals

MAX Power’s other key asset is its Wilcox Lithium Project in mining-friendly Cochise County in southeast Arizona where first-ever diamond drilling in late 2023/early 2024 confirmed the discovery of near-surface lithium-rich clays over a broad area of the Willcox Playa. MAX Power’s property occurs within a nearly 4,000-acre corridor adjacent to U.S. Department of Defense land, and benefits from direct access through roads, rail and power infrastructure. The discovery was made just as lithium entered its final price downturn and is now being intensely revisited by the company in light of the turnaround in lithium and an emphasis on critical mineral resource development in the United States under the Trump administration.

Market Opportunity

According to company materials, the global hydrogen market is valued at approximately $250 billion and is expected to surpass $400 billion by 2030. Supporting this outlook, a study published in Science Advances (Dec. 2024) estimates that in-place natural hydrogen resources could meet global net-zero carbon goals for roughly 200 years. Closer to home, a feasibility study by the Transition Accelerator (April 2024) projects that the Regina-Moose Jaw Industrial Corridor (RMJIC) in Saskatchewan could support a C$708 million annual hydrogen market, with province-wide demand reaching as high as C$2.7 billion per year.

These projections underscore a compelling opportunity to establish a new energy economy centered around natural hydrogen—a low-cost, low-emission, and potentially naturally replenishing resource. MAX Power is well-positioned to lead this effort with proximity to infrastructure, favorable geology, and increasing institutional support.

Leadership Team

Mansoor Jan, CEO, brings more than two decades of international experience across mining operations, capital markets, and business development. He has held senior positions at BHP Australia, BHP Chile, and Rio Tinto, where he was responsible for advancing cross-border projects, driving mine optimization, and leading technology delivery across major jurisdictions. Mr. Jan holds a BA and MSc in Economics and a Master of Commerce from the University of New South Wales in Australia.

Neil McMillan, Director and Chair of the Audit Committee, is the former Chairman of the Board of Cameco, the world’s largest publicly traded uranium company. Mr. McMillan served on Cameco’s board for 16 years and is highly regarded within and outside the province for his decades of success there. He previously led Claude Resources as President and CEO, paving the way for its development into Saskatchewan’s only profitable gold miner which was bought out for more than $300 million by Silver Standard Resources in 2014.

Steve Halabura, Chief Geoscientist, has decades of successful experience in the province’s resource sector including a deep understanding of the geological controls on the accumulation of hydrogen, helium, and other industrial gases. He was also instrumental in the early formative stages of the only two Saskatchewan greenfield potash mines to come into existence in the 21st century, these being BHP’s Jansen Project and K+S’s Bethune mine. Jansen is the largest private investment ($14 billion) in Saskatchewan history and is located northeast of MAX Power’s Genesis Trend.

Tom Kishchuk, MAX Power’s Senior Strategic Advisor for Natural Hydrogen Development, is CEO for the Saskatchewan-based Global Institute for Energy, Mines and Society (GIEMS). He has over three decades of technical and business leadership in national and global organizations focused on the energy sector.

MAX Power Mining Corp. (OTC: MAXXF), closed Thursday's trading session at $0.758205, up 8.2841%, on 90,730 volume. The average volume for the last 3 months is 5,665,230 and the stock's 52-week low/high is $0.99/$4.04.

Recent News

• MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) - Michigan Announces New Geologic Hydrogen Exploration Initiative
• Could 2026 Usher in Increased Trading of Tokenized Copper?
• MiningNewsBreaks - MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) Identifies Near-Term Bracken Well Target for Second Natural Hydrogen Play in Saskatchewan